Eurofins Discovery Acquires CALIXAR, Expanding Integrated Drug Discovery Capabilities and Expertise

April 6, 2023

CALIXAR is proud to be part of Eurofins Discovery and Eurofins DiscoverX® and supports their strategy to be the partner of choice to the pharmaceutical and biotech industry.

Read the article

Expression of fully native proteins

Identification of relevant targets

Target functional isolation and stabilization

Active custom proteins

Structure-based drug discovery

Immunoassays

Vaccine development

Functional antigen discovery

Conformational antibody development

Expression of fully native proteins

Identification of relevant targets

Target functional isolation and stabilization

Active custom proteins

Structure-based drug discovery

Immunoassays

Vaccine development

Functional antigen discovery

Conformational antibody development

Secure and boost
your discovery programs

Starting from native material or recombinant systems, we succeed with all types of proteins: Kinases, Phosphatases, Ubiquitins, Epigenetic Proteins, GPCRs, Ion Channels, Transporters, Receptors and Viral Proteins.